Previous studies suggested that AML-associated translocations, such as t(8;21) and t(15;17), contributed to the activation of gamma-catenin, or that FLT3 mutation might be associated with the stabilization of beta-catenin. This evidence concerns the gene JUP and acute myeloid leukemia.